Living With Extreme Myopia (-20 and Above) — ICL, Retinal Risk, and What's Actually Possible

High Myopia With Multiple Complications — When to Pursue Refractive Surgery and When to Wait

The Decision Tree Nobody Talks About

A 24-year-old with -13 myopia, keratoconus, early cataract, and retinal scarring is asking: Should I get ICL surgery now?

This specific scenario—high myopia + structural corneal disease + crystalline lens pathology + retinal history—sits in the gray zone where standard refractive surgery guidelines don't directly apply. The evidence is limited, and the stakes are high.

The Surgical Options at -13

ICL (Implantable Collamer Lens):

• Approved for myopia up to -18 diopters
• Non-ablative (doesn't remove corneal tissue)
• Reversible (theoretically)
• Risk: endothelial cell loss, cataract progression, ICL-induced inflammation

• Directly addresses early PSC
• Permanent (lens removal is irreversible)
• Can achieve high refractive correction with premium IOLs
• Risk: posterior capsule opacification, IOL dislocation in high myopia, loss of accommodation

• Not standard; interactions between ICL and cataract surgery are poorly studied

The Case for Waiting: Early Cataract Changes Are Unpredictable

Early posterior subcapsular (PSC) cataract progression is notoriously variable:

Chylack et al. (1993) — Longitudinal 5-year follow-up of PSC (Arch Ophthalmol):

• Some PSC cases remained stable or progressed minimally over 10 years
• Others progressed to visually significant cataract within 2–3 years
• Age, baseline density, and rate of change were poor predictors

Key implication: If your PSC is truly early (not reducing BCVA), waiting 1–2 years and reassessing is reasonable. If it progresses, cataract surgery + IOL becomes a single definitive procedure (avoiding future ICL complications and addressing myopia simultaneously).

The Case for ICL Now: Keratoconus Compatibility

Keratoconus is a relative contraindication to corneal refractive surgery (LASIK, PRK) but not to ICL. In fact, ICL may be superior to other options in mild keratoconus:

Kamiya et al. (2012) — ICL in keratoconus eyes (J Cataract Refract Surg):

• 47 eyes with mild-to-moderate keratoconus treated with ICL
• Significant improvement in BCVA and refractive error
• No ICL-induced keratoconus progression
• Complication rate: 2.1% (low)

The Retinal Scarring Factor

Retinal scars (from prior laser barrage or retinal tear repair) are not a contraindication to ICL, but they do require specialist assessment:

Action items before ICL:

If retinal status is stable, ICL is typically safe.

The Evidence: What Happens to ICL in High Myopia Long-Term?

Alfonso et al. (2020) — 10-year ICL outcomes (J Cataract Refract Surg):

• 256 eyes with high myopia (mean -15 diopters) followed for ≥10 years
• Endothelial cell loss: 2.2% per year (cumulative ~20% at 10 years)
• Cataract incidence: 5.9% at 10 years (similar to natural progression in high myopia without ICL)
• Visual outcomes: 95% achieving 20/40 or better corrected vision

Decision Framework

Wait on ICL if:

• Cataract is early and not progressing (BCVA >20/40)
• Retinal status is complex and requires clearer definition
• You want to observe keratoconus behavior first
• You prefer to defer ICL until cataract definitively progresses

• Keratoconus is confirmed but mild and non-progressive
• Retinal evaluation is complete and normal
• Functional vision is limiting daily life
• You're ready for a reversible optical intervention while awaiting possible future cataract surgery

• Trial period (3–6 months) clarifies lens tolerance
• Allows keratoconus monitoring without surgical commitment
• Bridges the gap until cataract/refraction picture clears

Recommended Consultation Sequence

The Bottom Line

High myopia + keratoconus + early cataract + retinal history = complexity that requires specialist collaboration, not a standard ICL decision. Waiting 6–12 months for the cataract picture to clarify, while trialing contact lenses, is evidence-based caution—not hesitation.

---